Quest Diagnostics Incorporated’s (DGX) third-quarter 2024 adjusted earnings per share (EPS) of 2.30beattheZacksConsensusEstimateby1.82.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted figure by 3.6%.Certain one-time expenses, like the ones related to amortization expenses, certain restructuring and integration charges, other expenses and excess tax benefits associated with stock-based compensations, were excluded from the quarter’s adjusted figures.GAAP earnings came in at 2.30beattheZacksConsensusEstimateby1.81.99 per share, up 1.5% fr ...
Quest Diagnostics(DGX) ZACKS·2024-10-22 14:40